Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions.

<h4>Introduction</h4>Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPE...

Detaylı Bibliyografya
Asıl Yazarlar:	Thomas W Georgi, Lars Kurch, Dirk Hasenclever, Victoria S Warbey, Lucy Pike, John Radford, Osama Sabri, Regine Kluge, Sally F Barrington
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science (PLoS) 2023-01-01
Seri Bilgileri:	PLoS ONE
Online Erişim:	https://doi.org/10.1371/journal.pone.0283694

Benzer Materyaller

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
Yazar:: Thomas W Georgi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
Yazar:: Lars Kurch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
Yazar:: Regine Kluge, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
Yazar:: M. André, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Automatic classification of lymphoma lesions in FDG-PET–Differentiation between tumor and non-tumor uptake
Yazar:: Thomas W Georgi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
Yazar:: Thomas W Georgi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
Yazar:: Karan L. Chohan, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
Yazar:: Akram Al-Ibraheem, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Interim PET for prognosis in adults with Hodgkin lymphoma: A prognostic factor exemplar review
Yazar:: Skoetz, N, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
Yazar:: Diego Villa, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Prevention of activated brown adipose tissue on 18F-FDG-PET scans of young lymphoma patients: results of an ancillary study within the EuroNet-PHL-C2 trial
Yazar:: C. Pötzsch, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
Yazar:: Elizabeth Katherine Anna Triumbari, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
Yazar:: L. Kurch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
Yazar:: Tseng Diane, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Hodgkin lymphoma: hypodense lesions in mediastinal masses
Yazar:: Adrian Damek, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies
Yazar:: Aldin, A, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Interim PET‐results for prognosis in adults with Hodgkin lymphoma: A systematic review and meta‐analysis of prognostic factor studies
Yazar:: Aldin, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
Yazar:: Chiara Rusconi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA
Yazar:: M. C. Pirosa, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
Yazar:: Arun Seshachalam, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Baskı/Yayın Bilgisi: (2018-10-01)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
Yazar:: Chiara Rusconi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
Yazar:: Josée M. Zijlstra, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA Hodgkin lymphoma
Yazar:: Radford, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
Yazar:: Tim M. Illidge, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
Yazar:: Eleonora Calabretta, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

P026 (0057) INTERIM- PET RESULTS FOR PROGNOSIS IN ADULTS WITH HODGKIN LYMPHOMA: A PROGNOSTIC FACTOR EXEMPLAR REVIEW (PRELIMINARY RESULTS)
Baskı/Yayın Bilgisi: (2018-10-01)

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials
Yazar:: Simonetta Viviani, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
Yazar:: Lars Kurch, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

The role of FDG-PET in Hodgkin lymphoma
Yazar:: Edyta Subocz, ve diğerleri
Baskı/Yayın Bilgisi: (2017-06-01)

Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients
Yazar:: Afnan A. Malaih, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
Yazar:: Elske Quak, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Yazar:: Andrea Gallamini, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

The utility of PET/CT with 18F-FDG in the study of Hodgkin's lymphoma and non-Hodgkin's lymphoma
Yazar:: Marta Milhões, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
Yazar:: Stephen Daw, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

T020: Interim PET-guided treatment of early-stage nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the GHSG HD16 and HD17 studies
Yazar:: Dennis A. Eichenauer, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group
Yazar:: Aznar, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
Yazar:: Francesca Maccioni, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
Yazar:: Özgür Ömür, ve diğerleri
Baskı/Yayın Bilgisi: (2014-03-01)

Machine Learning to Predict Interim Response in Pediatric Classical Hodgkin Lymphoma Using Affordable Blood Tests
Yazar:: Jennifer A. Geel, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)